UCLA In the News June 28, 2017

UCLA In the News lists selected mentions of UCLA in the world’s news media. See more UCLA In the News.

111 have utilized right-to-die law in California  | Los Angeles Times

Often patients have long-held values and beliefs about what makes a life worth living, and want the peace of mind of knowing that if their conditions worsen, their pain increases, or they become more dependent on others, they won’t have to endure it, said Dr. Tom Strouse, a psychiatrist and palliative care doctor at UCLA. They “want the option of saying, ‘That’s not how I’m going to live,’” Strouse said. “It’s a contingency planning approach, really.”

What is ransomware? | Associated Press

“Ransomware, like the name suggests, is when your files are held for ransom,” says Peter Reiher, a UCLA professor who specializes in computer science and cybersecurity. “It finds all of your files and encrypts them and then leaves you a message. If you want to decrypt them, you have to pay.”

Fewer admissions for heart failure, but blacks still fare worse | Reuters Health

“These findings are impressive and suggest that efforts to prevent heart failure and improve the outpatient treatment of heart failure have had overall success in reducing the number of heart failure patients needing hospitalizations,” senior study author Dr. Gregg C. Fonarow from David Geffen School of Medicine at University of California, Los Angeles told Reuters Health. “However, the improvements were not equally distributed across race/ethnicities and genders, and additional efforts are needed.” (Also: Medical Xpress, Dr. Boback Ziaeian quoted)

Supreme Court travel ban ruling no victory for Trump | Forbes

“My initial reaction is that this decision is less a ‘victory’ for the President than he (and some media outlets, including some major outlets) are portraying it to be,” says Hiroshi Motomura, an immigration specialist at UCLA School of Law.

Racing toward deeper understanding of autism biology | Spectrum

“Most of the genetic advances fall into a category of large-effect-size de novo variants, which is only one piece of the puzzle,” says Daniel Geschwind, professor of human genetics at the University of California, Los Angeles. 

Media Contact